Rebecca C. C. Chan

Rebecca C. C. Chan is the Chief Financial Officer at Cloudbreak Pharma since March 2022, bringing extensive expertise in financial leadership garnered from previous roles, including National Capital Market Group Leader at Deloitte China and Partner positions at KPMG and PwC, where involvement focused on capital markets. Prior experience includes serving as Co-head of the IPO Department and Head of Accounting Affairs at Hong Kong Exchanges and Clearing Limited. Educational credentials comprise a Bachelor's Degree in Law from the University of London and an MBA in Finance from The Hong Kong University of Science and Technology, along with membership in the Hong Kong Institute of Certified Public Accountants and the Institute of Chartered Accountants in England and Wales.